4//SEC Filing
Doyle Noah 4
Accession 0001209191-20-019349
CIK 0001460702other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:53 PM ET
Size
7.1 KB
Accession
0001209191-20-019349
Insider Transaction Report
Form 4
Doyle Noah
Director
Transactions
- Sale
Common Stock
2020-03-12$0.22/sh−500,000$110,000→ 704,780 total(indirect: By Javelin Partners, L.P.)
Holdings
- 32,275(indirect: By LLC)
Common Stock
- 2,272
Common Stock
Footnotes (3)
- [F1]The Reporting Person sold the securities in open market transactions at prices ranging from $0.22 to $0.23 per share, with a weighted average sale price of $0.22 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer or a securityholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]As the managing director of Javelin Partners, L.P., the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.
- [F3]As the managing director of Javelin Venture Partners I SPV I, LLC, the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.
Documents
Issuer
RITTER PHARMACEUTICALS INC
CIK 0001460702
Entity typeother
Related Parties
1- filerCIK 0001631673
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:53 PM ET
- Size
- 7.1 KB